CeriBell, Inc (NASDAQ:CBLL) — Market Cap & Net Worth
Market Cap & Net Worth: CeriBell, Inc (CBLL)
CeriBell, Inc (NASDAQ:CBLL) has a market capitalization of $936.81 Million ($936.81 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9229 globally and #2588 in its home market, demonstrating a 2.42% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CeriBell, Inc's stock price $25.00 by its total outstanding shares 38378101 (38.38 Million). Also see CeriBell, Inc assets under control for a full breakdown of the balance sheet.
CeriBell, Inc Market Cap History: 2024 to 2026
CeriBell, Inc's market capitalization history from 2024 to 2026. Data shows growth from $993.23 Million to $959.45 Million (22.03% CAGR). Also see CBLL cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
CeriBell, Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.04% | #263 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #976 of 3165 |
Weight: CeriBell, Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CeriBell, Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CeriBell, Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CeriBell, Inc share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
9.45x
CeriBell, Inc's market cap is 9.45 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $993.23 Million | $65.44 Million | -$40.45 Million | 15.18x | N/A |
| 2025 | $841.63 Million | $89.06 Million | -$53.41 Million | 9.45x | N/A |
Competitor Companies of CBLL by Market Capitalization
Companies near CeriBell, Inc in the global market cap rankings as of September 18, 2026. Review how tangible is CeriBell, Inc's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to CeriBell, Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
CeriBell, Inc Historical Marketcap From 2024 to 2026
Between 2024 and today, CeriBell, Inc's market cap moved from $993.23 Million to $ 959.45 Million, with a yearly change of 22.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $959.45 Million | +14.00% |
| 2025 | $841.63 Million | -15.26% |
| 2024 | $993.23 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of CeriBell, Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $936.81 Million USD |
| MoneyControl | $936.81 Million USD |
| MarketWatch | $936.81 Million USD |
| marketcap.company | $936.81 Million USD |
| Reuters | $936.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more